How should I evaluate and manage a 71-year-old woman with a normal hematocrit and macrocytosis (MCV 103.7 fL, MCH 33.8 pg)?

Evaluation and Management of Macrocytosis Without Anemia in a 71-Year-Old Woman

This 71-year-old woman with macrocytosis (MCV 103.7 fL) and normal hematocrit requires a systematic workup starting with vitamin B12 and folate levels, reticulocyte count, peripheral blood smear examination, and assessment for common causes including medications, alcohol use, hypothyroidism, and liver disease.

Initial Diagnostic Approach

The morphologic classification of anemia based on MCV is well-established, with macrocytosis defined as MCV >100 fL 1. However, macrocytosis can occur without anemia and still indicates underlying pathology that requires investigation 2.

Essential First-Line Testing

The minimum workup should include 3:

• Complete blood count with differential - to assess all cell lines
• Reticulocyte count - distinguishes between decreased production versus increased destruction/loss
• Peripheral blood smear - identifies macro-ovalocytes, hypersegmented neutrophils (megaloblastic), or other morphologic abnormalities
• Vitamin B12 and folate levels - most common megaloblastic causes
• Thyroid function tests - hypothyroidism causes macrocytosis
• Liver function tests - liver disease is a frequent cause
• Comprehensive medication review - many drugs cause macrocytosis

Algorithmic Classification

With normal or low reticulocytes (indicating production defect) 3:

The differential includes:

• Vitamin B12 deficiency - even without anemia, 20.9% of B12-deficient patients present with isolated macrocytosis 2
• Folate deficiency - less common but important to exclude
• Medications - azathioprine, hydroxyurea, methotrexate, antiretrovirals 1, 3
• Hypothyroidism - routinely screen
• Liver disease/alcohol use - alcohol is among the most common causes 4, 5
• Myelodysplastic syndrome (MDS) - critical consideration in elderly patients

With elevated reticulocytes (indicating appropriate marrow response):

• Hemolysis should be investigated with haptoglobin, LDH, indirect bilirubin 3
• Recent blood loss with recovery

Critical Considerations for This Patient

Age-Related Risk Factors

At 71 years old, MDS becomes a significant diagnostic consideration 4. MDS commonly presents with macrocytosis in the elderly and may initially manifest without anemia. A scoring system incorporating age ≥65, elevated MCV, elevated RDW, and elevated LDH can help stratify MDS risk 6.

When to Suspect MDS

Consider hematology referral and bone marrow evaluation if 7, 4:

• Cytopenias in multiple cell lines (leukopenia, thrombocytopenia)
• Progressive macrocytosis
• Elevated RDW (>15%)
• Unexplained macrocytosis after excluding common causes
• Peripheral smear shows dysplastic features

Megaloblastic vs Non-Megaloblastic Distinction

Peripheral smear findings are crucial 3:

• Megaloblastic: Macro-ovalocytes (72% of cases) and hypersegmented neutrophils (86% of cases) strongly suggest B12 or folate deficiency 2
• Non-megaloblastic: Round macrocytes suggest alcohol, liver disease, hypothyroidism, or MDS 4, 8

Management Algorithm

Step 1: Exclude Common Reversible Causes

1. Medication review - drugs are the most common cause in hospitalized patients 5
2. Alcohol history - second most common cause 5
3. Thyroid and liver function - readily treatable conditions

Step 2: Assess for Nutritional Deficiencies

• If B12 <200 pg/mL: Consider methylmalonic acid and homocysteine levels for confirmation 5
• If folate deficient: Supplement appropriately
• Note: 9 cases (20.9%) of B12 deficiency presented with isolated macrocytosis without anemia 2, emphasizing the importance of not dismissing macrocytosis simply because hemoglobin is normal

Step 3: Risk Stratification for MDS

If common causes excluded and patient has:

• Age ≥65 years
• MCV >103 fL
• Elevated RDW
• Any other cytopenia

Strongly consider hematology referral for bone marrow evaluation 6. The post-test probability of MDS increases from 12% with no risk factors to 48% with three or more factors present.

Common Pitfalls to Avoid

1. Dismissing macrocytosis because hematocrit is normal - Macrocytosis without anemia may be the first clue to underlying pathology and requires full evaluation 2

2. Failing to examine the peripheral smear - Morphology provides critical diagnostic information distinguishing megaloblastic from non-megaloblastic causes 3

3. Not considering MDS in elderly patients - As the population ages, primary care physicians will encounter more MDS cases 4. Early recognition improves outcomes

4. Overlooking medication-induced macrocytosis - This is the most common cause and easily reversible if the drug can be discontinued 5

5. Assuming normal B12 levels exclude deficiency - Consider methylmalonic acid and homocysteine if clinical suspicion remains high despite borderline B12 levels 5

Follow-Up Strategy

• If reversible cause identified: Treat and recheck CBC in 8-12 weeks
• If B12/folate deficiency: Supplement and monitor response
• If unexplained after initial workup: Hematology referral for consideration of bone marrow biopsy, particularly given patient's age and MDS risk 4, 6